Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 9/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.41 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.33 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9465032 | 0.70 | CYP2A6 (0.42) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL27989815 | 0.65 | CYP2A6 (0.74) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL13977897 | 0.64 | CYP2A6 (0.50) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL19148272 | 0.64 | CYP2A6 (0.50) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL8034177 | 0.63 | CYP2A6 (0.39) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| Formaldehyde SCHEMBL28680174 | 0.63 | CYP2A6 (0.62) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL30714232 | 0.62 | — | — | |
| SCHEMBL1356085 | 0.62 | CYP17A1 (0.70) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL29136542 | 0.61 | CYP2A6 (0.59) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 | |
| SCHEMBL22734811 | 0.61 | CYP2A6 (0.52) | CYP2A6CYP2B6CYP2E1KCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2654749-B1 | METHODS FOR TREATING COPD | UNIV TEXAS (US) | 2017-05-10 | — | — | EP | disclosed |
| US-9198915-B2 | Methods involving aldose reductase inhibitors | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-12-01 | — | — | US | disclosed |
| US-9186362-B2 | Methods involving aldose reductase inhibitors | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-11-17 | — | — | US | disclosed |
| EP-2848252-A2 | Aldose reductase inhibitors for use in treating uveitis | The Board of Regents of the University of Texas System (US) | 2015-03-18 | — | — | EP | disclosed |
| US-8785483-B2 | Methods for treating COPD | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-07-22 | — | — | US | disclosed |
| US-20130096111-A1 | Methods Involving Aldose Reductase Inhibitors | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-04-18 | — | — | US | disclosed |
| US-20130023529-A1 | Methods Involving Aldose Reductase Inhibitors | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-01-24 | — | — | US | disclosed |
| US-8273746-B2 | Methods involving aldose reductase inhibitors | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-09-25 | — | — | US | disclosed |
| US-20120238609-A1 | Methods for Treating COPD | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-09-20 | — | — | US | disclosed |
| US-20100144748-A1 | METHODS INVOLVING ALDOSE REDUCTASE INHIBITORS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2010-06-10 | — | — | US | disclosed |
| US-20090270490-A1 | METHODS INVOLVING ALDOSE REDUCTASE INHIBITION | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2009-10-29 | — | — | US | disclosed |
| US-20060293265-A1 | Methods involving aldose reductase inhibitors | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2006-12-28 | — | — | US | disclosed |
| US-6696407-B1 | ADMINISTERING OXIDOREDUCTASE ENZYME INHIBITORS SUCH AS TOLRESTAT OR PONALRESTAT TO INCREASE ENDOGENOUS CILIARY NEUROTROPHIC FACTOR (CNTF), FOR PREVENTION OR PROPHYLAXIS OF NEURODEGENERATIVE DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-02-24 | — | — | US | disclosed |
| EP-0421365-B1 | Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity | WAKAMOTO PHARMA CO LTD (JP) | 1997-03-05 | — | — | EP | disclosed |
| EP-0421365-A2 | Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1991-04-10 | — | — | EP | disclosed |